Southern Home Medicl
Southern Home Medical, Inc. provides healthcare services to medical institutions in the United States. It supplies breathing equipment for patients with respiratory conditions; and oxygen concentrators, portable oxygen tanks, hospital beds, alternating pressure mattresses, patient lifts, tracheotomy supplies, commodes, walkers, and wheelchairs. The company also provides medical staffing needs to … Read more
Southern Home Medicl (SHOM) - Net Assets
Latest net assets as of March 2017: $123.81K USD
Based on the latest financial reports, Southern Home Medicl (SHOM) has net assets worth $123.81K USD as of March 2017.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($220.23K) and total liabilities ($96.42K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $123.81K |
| % of Total Assets | 56.22% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Southern Home Medicl - Net Assets Trend (2009–2016)
This chart illustrates how Southern Home Medicl's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Southern Home Medicl (2009–2016)
The table below shows the annual net assets of Southern Home Medicl from 2009 to 2016.
| Year | Net Assets | Change |
|---|---|---|
| 2016-12-31 | $157.02K | -58.48% |
| 2014-12-31 | $378.17K | +1251.37% |
| 2011-12-31 | $-32.84K | +69.96% |
| 2010-12-31 | $-109.33K | +23.99% |
| 2009-12-31 | $-143.83K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Southern Home Medicl's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 59328900.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2016)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $7.02K | 4.47% |
| Common Stock | $102.91K | 65.54% |
| Other Components | $47.09K | 29.99% |
| Total Equity | $157.02K | 100.00% |
Southern Home Medicl Competitors by Market Cap
The table below lists competitors of Southern Home Medicl ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Baristas Coffee Company Inc
PINK:BCCI
|
$0.99 |
|
Placer Creek Mining
OTCGREY:PRCK
|
$0.99 |
|
United Resource Holdings Group Inc
PINK:URHG
|
$0.99 |
|
JPO Solutions Inc
PINK:MOPN
|
$0.99 |
|
Powerlock Intl Corp
PINK:PWLK
|
$0.99 |
|
Avistar Communications Corp
PINK:AVSR
|
$0.99 |
|
Helmer Directional
PINK:EXLA
|
$0.99 |
|
Odyne Corporation
PINK:ODYC
|
$0.99 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Southern Home Medicl's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2014 to 2016, total equity changed from 340,336 to 157,019, a change of -183,317 (-53.9%).
- Net income of 7,019 contributed positively to equity growth.
- Other factors decreased equity by 190,336.
Equity Change Factors (2014 to 2016)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $7.02K | +4.47% |
| Other Changes | $-190.34K | -121.22% |
| Total Change | $- | -53.86% |
Book Value vs Market Value Analysis
This analysis compares Southern Home Medicl's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Southern Home Medicl utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.47%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.91%
- • Asset Turnover: 1.80x
- • Equity Multiplier: 1.31x
- Recent ROE (4.47%) is above the historical average (-3.19%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 0.00% | -2.99% | 1.08x | 0.00x | $-4.55K |
| 2010 | 0.00% | 4.13% | 5.37x | 0.00x | $53.25K |
| 2011 | 0.00% | 7.64% | 3.40x | 0.00x | $89.46K |
| 2014 | -20.41% | -13.85% | 1.15x | 1.29x | $-103.49K |
| 2016 | 4.47% | 1.91% | 1.80x | 1.31x | $-8.68K |
Industry Comparison
This section compares Southern Home Medicl's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Southern Home Medicl (SHOM) | $123.81K | 0.00% | 0.78x | $0.99 |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |